As GNG4 is highly expressed in exhausted CD4+ T cells and its higher expression is correlated with immune infiltration, we investigated whether GNG4 could be used as a biomarker to predict the immunotherapeutic response to BLCA. This evidence concerns the gene CD4 and bladder transitional cell carcinoma.